Avanir is still riding gains made since wednesday's announcement of positive results of Zenvia in diabetic neuropathy.
Minutes before the market closes today AVNR is up 11.5%, (that's another 46 cents a share ) to $4.37.
This stock might hit 10 dollars before this is all over!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment